Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

CD Bioparticles Launches Beads Based Multiplex Assay for High-Throughput Biomarker Detection

CD Bioparticles launches Beads Based Multiplex Assay services for preclinical and clinical research.

(PRUnderground) July 21st, 2025

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the launch and expanded availability of its cutting-edge Beads Based Multiplex Assay services for researchers to simultaneously measure up to 500 analytes from a single sample, significantly enhancing the efficiency and precision of preclinical and clinical research.

Measuring soluble cytokines and other analytes in serum and plasma is becoming increasingly important in studying and treating many diseases. Consequently, there is a growing need for the rapid, accurate, and cost-effective measurement of these analytes in clinical and research laboratories. Multiplex bead array assays use an automated 96-well plate format to quantify large numbers of analytes. Although enzyme-linked immunosorbent assays (ELISA) are the standard for the quantitative analysis of cytokines and other biomarkers, they are not suitable for high-throughput, multiplexed analysis.

CD Bioparticles now offers researchers customized multiplex assays based on Luminex xMAP technology. The CD-Multiplex™ bead-based multiplex system can detect up to 500 analytes in a single sample, meeting the needs of preclinical and clinical research. The system allows scientists to use a smaller sample volume in a high-throughput format, making it easier and more efficient to obtain accurate results.

The CD-Multiplex™ system uses magnetic beads modified with unique fluorophores of varying intensities. Individual magnetic beads are distinguished from others by unique numbering, and each group of beads is conjugated to a custom antibody that detects a specific analyte. Multiple color-coded, antibody-conjugated beads are added to a single well of a microtiter plate, enabling the simultaneous detection of multiple analytes in a sample. This CD-Multiplex™ assay undergoes stringent quality control and validation to ensure its reliability and specificity.

CD Bioparticles’ multiplex cytokine assay solutions are widely used in various fields, including immunology, oncology and drug development. For example, they’re essential tools for oncology, which enables the detection of markers in tumor environments and the evaluation of treatment effectiveness. Additionally, they are used in toxicology to assess toxicity biomarkers during drug candidate evaluation. They also play a key role in vaccine development by profiling vaccine-induced immune responses. Furthermore, CD Bioparticles’ multiplex bead array assays facilitate translational studies by integrating in vitro, ex vivo, and in vivo biomarker data.

CD Bioparticles’ custom Luminex bead-based multiplex assay services support all phases of a research project, from panel design, bead conjugation, validation, testing to data delivery. For example, CD Bioparticles offers the Robust Cross-reactivity Validation service through careful optimization of each antibody-bead conjugate to ensure specificity. With flexible panel sizes ranging from two to 500 analytes, CD Bioparticles can support researchers whether they’re validating a few biomarkers or profiling an entire proteome. In addition, CD Bioparticles performs comprehensive quality control on every custom multiplex bead-based immunoassay to ensure sensitivity, specificity, dynamic range, and reproducibility.

To learn more about CD Bioparticles’ custom Bead-Based Multiplex Assay services, please visit https://www.cd-bioparticles.com/s/Beads-Based-Multiplex-Assay_29.html.

About CD Bioparticles

CD Bioparticles specializes in manufacturing and supplying nanoparticles, microparticles, and coatings for diagnostics and research, alongside developing customized, biocompatible drug delivery systems. We offer diverse formulation technologies (from liposomes to polymer nanoparticles) and comprehensive services, including surface functionalization, antibody immobilization, and contract research for drug delivery.

The post CD Bioparticles Launches Beads Based Multiplex Assay for High-Throughput Biomarker Detection first appeared on

Press Contact

Name: Richard J. Gray
Phone: 1-631-346-0027
Email: Contact Us

Original Press Release.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.